CARDIAC RHYTHM MANAGEMENT (CRM) DEVICES EMERGING MARKETS (BRAZIL, RUSSIA, INDIA, CHINA, SOUTH AFRICA AND SOUTH

H KOREA), 2009-2015

PUBLICATION:FEBRUARY,2011|REPORTCODE:ARMMR123 REPORTPRICE:$2550|NO.OFPAGES:409 TABLES/CHARTS:102

CURRENTTRENDS,ESTIMATESANDFORECASTS, MARKETGROWTHANALYSIS20092015
PRIMARILYFOCUSESON: LATESTMARKETTRENDS,REGIONWISEDEMANDFACTOR,KEYGROWTHAREAS, MARKETSIZES,KEYCOMPETITORSEDGE,INVESTMENTSTRATEGIES

www.axisresearchmind.com | Copyright 2011 | All Rights Reserved

CARDIACRHYTHMMANAGEMENT(CRM)DEVICESEMERGINGMARKETS (BRAZIL,RUSSIA,INDIA,CHINA,SOUTHAFRICAANDSOUTHKOREA),20092015
REPORTPRICE:$2550 NO.OFPAGES:409|TABLES/CHARTS:102

PUBLICATION:FEBRUARY,2011

REPORTCODE:ARMMR123

CARDIACRHYTHMMANAGEMENT(CRM)DEVICES
CARDIACDEFIBRILLATORS IMPLANTABLECARDIOVERTERDEFIBRILLATORS(ICD) EXTERNALDEFIBRILLATINGDEVICESOR AUTOMATEDEXTERNALDEFIBRILLATOR(AED) CARDIACPACEMAKERS IMPLANTABLEPACEMAKERS(SINGLECHAMBER PACEMAKERSANDDUALCHAMBERPACEMAKERS) EXTERNALPACEMAKERS CARDIACRESYNCHRONIZATIONTHERAPY(CRT) CARDIACRESYNCHRONIZATIONTHERAPY DEFIBRILLATOR(CRTD) CARDIACRESYNCHRONIZATIONPACEMAKERS(CRTP) OTHERS SURGICALABLATION OTHERS

REPORTFOCUS
The report Cardiac Rhythm Management (CRM) Devices Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 20092015 reviewsthelatesttrendsintheCRMdevicesmarketwith a perceptive attempt to disclose the nearfuture growth prospects. An indepth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnologycompanies,laboratories,ContractResearch Organizations (CROs), government organizations and manymoreinpreferredlocations. Estimates are based on online surveys using customized questionnairesbyourresearchteam.Besidesinformation from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry. Anticipating a protractedrecoverytowards2011,wehaveusedCAGRto forecast20112015figures. More than 608 leadingmarketplayersare identifiedand 82keycompaniesincardiacmedicaldevicesindustrythat project improved marketactivities in the nearfutureare profiled.Thereportconsistsof102datachartsdescribing

BRICSSCARDIACRHYTHM MANAGEMENT(CRM)DEVICES CAGR%BREAKDOWN BYREGION,20092015

CAGR - %

the market shares, sales forecasts and growth prospects. Moreover,keystrategicactivitiesinthemarketincluding mergers/acquisitions, collaborations/partnerships, productlaunches/developmentsarediscussed.

Get Access To Winning Investment Strategies Over Your Competitors!!!

Russia South Africa South Korea Brazil China India

The period considered for the market analysis is 20092015. Incorporatingtherecessionimpactsontheindustry,themarket growth rate in these economies are estimated individually for theupcomingyears.

Formoreinformationonthisreport,pleasereachusat:sales@axisresearchmind.com

Copyright 2011 | Axis Research Mind | All Rights Reserved

CARDIACRHYTHMMANAGEMENT(CRM)DEVICESEMERGINGMARKETS (BRAZIL,RUSSIA,INDIA,CHINA,SOUTHAFRICAANDSOUTHKOREA),20092015
REPORTPRICE:$2550 NO.OFPAGES:409|TABLES/CHARTS:102

PUBLICATION:FEBRUARY,2011

REPORTCODE:ARMMR123

BRICSSMARKETWATCH

GEOGRAPHICCOVERAGE

BRAZIL
Thebroadhealthcaredivisionhasbeenwitnessingarapidgrowth andtechnologicalimprovementsvaryingfromsectortosectorsince thepast35years.Theevolutionofcardiacdeviceshasopenednew vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirmsthepositivegrowthprospectsgoingahead. BRICSS Cardiac Rhythm Management (CRM) Devices market forecaststoreachatUS$3.6billionby2015ataCAGRof10.3% during the analysis period 20092015. China accounts for more than 25% of the global value and India claims almost a closer value of the BRICSS market. In terms of CAGR, India and China arethefastestgrowingregionwhileRussiaandSouthKoreaare just behind. Forecasts of BRICSS External Defibrillators market valuedepictnearlyhalfofImplantableCardioverterDefibrillator market by 2015. Forecasts of BRICSS External Pacemakers market value indicate approximately 40% while the rest is claimed by Implantable pacemakers sector. Similarly, BRICSS CRT defibrillator market value forecasts show approximately 45%whereas35%isclaimedbyCRTpacemakers.

RUSSIA INDIA CHINA SOUTHAFRICA

Copyright 2011 | Axis Research Mind | All Rights Reserved

SOUTHKOREA
ABIOMED, INC. ATRIUM MEDICAL CORP. IDEV TECHNOLOGIES CRYOLIFE INC. ADVANSOURCE BIOMATERIALS ATS MEDICAL, INC. CARDIOMEMS, INC.

KEYCOMPANIESPROFILED
MEDTRONIC, INC. AGA MEDICAL CORPORATION BIOPHAN TECHNOLOGIES, INC. CARDIACASSIST, INC. COOK GROUP INCORPORATED

ABBOTT VASCULAR DEVICES ATRICURE, INC BIOSENSE WEBSTER, INC. CARDICA, INC. CORDIS CORPORATION

BOSTON SCIENTIFIC CORP CARDIAC SCIENCE CORP. & many more

Formoreinformationonthisreport,pleasereachusat:sales@axisresearchmind.com

CARDIACRHYTHMMANAGEMENT(CRM)DEVICESEMERGINGMARKETS (BRAZIL,RUSSIA,INDIA,CHINA,SOUTHAFRICAANDSOUTHKOREA),20092015
REPORTPRICE:$2550 NO.OFPAGES:409|TABLES/CHARTS:102

PUBLICATION:FEBRUARY,2011

REPORTCODE:ARMMR123

KEYACTIVITIESINTHECARDIACMEDICALDEVICES MARKET
ABIOMEDRECEIVES510(K)CLEARANCEFROMFDAFORIMPELLA2.5DEVICE IMPELLA2.5ABIOMEDSPROMISINGDEVICEFORHEARTTREATMENT ABBOTTSUBMITSAPPLICATIONFORAPPROVALOFXIENCEVEVEROLIMUSELUTINGCORONARYSTENT ABIOMEDOBTAINED510(K)APPROVALFROMFDAFORIMPELLA2.5TOOL CARDIOTECHFORMSNEWSUBSIDIARY COMMENDATIONFROMFDAFORCOOKMEDICAL SIEMENSEFFORTTOMAKEACUSONACUNAVTECHNOLOGY,ASTANDARDOFCAREINELECTROPHYSIOLOGY. BIOPHANACQUIRESINTELLECTUALPROPERTYPORTFOLIOOFNANOSET,LLC FIRSTIMPLANTATIONOFAORTICMITRALALLOGRAFTHEARTVALVE FDAAPPROVESBOSTONSCIENTIFICSNEWFAMILYOFADVANCEDPACEMAKERS LAUNCHINGOFNEWPERIPHERALANGIOPLASTYBALLOONCATHETERS AUTOPULSENONINVASIVECARDIACSUPPORTPUMPANDLIFEVESTFULLYAUTOMATICWEARABLEDEFIBRILLATOR ADEVICETOREMOVENONFUNCTIONALANDINFECTEDCARDIACLEADSBYSPECTRANETICS SORINGROUPANDGREATBATCHDECLAREDACOLLABORATIVEAGREEMENTONMRITECHNOLOGY NEWVISION3DWIRELESSIMPLANTABLECARDIACDEVICESWASGIVENFDAAPPROVAL STARLOSESEVASCULARCLOSURESYSTEM ABBOTTLAUNCHESNEXTGENERATIONSTARCLOSESEVASCULARCLOSURESYSTEM ABIOCORE(R):ALIFESAVER,PATIENTFRIENDLYDEVICEBYABIOMED & many more
Copyright 2011 | Axis Research Mind | All Rights Reserved

GETTING THE MOST FROM OUR RESEARCH ANALYSIS

www.axisresearchmind.com

Formoreinformationonthisreport,pleasereachusat:sales@axisresearchmind.com